Illustrative image – not actual.
Hong Kong-listed Shanghai Fosun Pharmaceutical (Group) has agreed to buy Hyderabad-based Gland Pharma, backed by private equity giant KKR, for USD 1.4 billion.
The announcement of the deal of a Chinese drug maker buying an Indian company is expected to be made this week.
Gland Pharma, established in 1978, develops and manufactures generic injectables, primarily for the US market. It also sells its products in India and other semi-regulated markets.
